IPO Profile

FoxHollow Technologies
740 Bay Road, Redwood City, California 94063-2469
Tel: 650-421-8400
Web: www.foxhollowtech.com
Ticker: FOXH
Amount Raised: $63,000,000.00

Description:
We design, develop, manufacture and sell medical devices primarily for the treatment of peripheral artery disease. PAD results from the accumulation of plaque in arteries, most commonly occurring in the pelvis and legs. Plaque accumulation, known as atherosclerosis, causes the narrowing of arteries, thereby reducing the flow of oxygenated blood to tissue and organs. Left untreated, PAD increases the risk of heart attack, stroke, amputation or death. Our first product, the SilverHawk Plaque Excision System, is a minimally-invasive, disposable catheter system that treats PAD by removing plaque in order to reopen narrowed or blocked arteries. In June 2003, the U.S. Food and Drug Administration, or FDA, granted us 510(k) clearance to market the SilverHawk in the United States for treatment of atherosclerosis in the peripheral vasculature. We commenced full commercial introduction of the SilverHawk in the United States in January 2004. For the six months ended June 30, 2004, we sold over 7,000 devices primarily to more than 400 hospital customers in the United States and generated net revenue of $12.3 million.